Home › Funds › Venrock Adviser, LLC › COGT
Venrock Adviser, LLC position in COGT
COGENT BIOSCIENCES INC · Health Care
Venrock Adviser, LLC reported holding 1,642,166 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$52.6M, representing 2.55% of its reported portfolio and ranking #11 among its reported holdings. Venrock Adviser, LLC has disclosed COGT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Venrock Adviser, LLC's COGT position evolved
Venrock Adviser, LLC first disclosed a stake in COGT in Q3 2023 at 4,684,167 shares (US$45.7M). The position peaked in Q1 2026 at 2,000,000 shares, worth US$77.0M. Across 13 filings, Venrock Adviser, LLC increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 1,642,166 shares valued at US$52.6M. Notable position changes include a 50% trim in Q4 2025 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.68M | $45.67M | New |
| Q4 2023 | 4.68M | $27.54M | Hold |
| Q1 2024 | 5.13M | $34.47M | Add |
| Q2 2024 | 5.68M | $47.92M | Add |
| Q3 2024 | 5.68M | $61.39M | Hold |
| Q4 2024 | 5.68M | $44.34M | Hold |
| Q1 2025 | 5.68M | $34.05M | Hold |
| Q2 2025 | 4.76M | $34.14M | Reduce |
| Q3 2025 | 4.00M | $57.44M | Reduce |
| Q4 2025 | 2.00M | $71.04M | Reduce |
| Q1 2026 | 2.00M | $76.98M | Hold |
| Q2 2026 | 1.64M | $63.55M | Reduce |
| Q3 2026 | 1.64M | $52.58M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 50 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.96M sh · $190.74M · Q3 2026
- Fairmount Funds Management LLC 5.50M sh · $176.22M · Q3 2026
- Kynam Capital Management, LP 3.79M sh · $121.43M · Q3 2026
- TCG Crossover Management, LLC 2.50M sh · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M sh · $80.05M · Q3 2026
- Octagon Capital Advisors LP 2.35M sh · $75.25M · Q3 2026
- RTW INVESTMENTS, LP 2.31M sh · $73.93M · Q3 2026
- ORBIMED ADVISORS LLC 2.00M sh · $64.16M · Q3 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
- Commodore Capital LP 1.26M sh · $40.51M · Q3 2026
More on Venrock Adviser, LLC
FAQ
How long has Venrock Adviser, LLC held COGT?
Venrock Adviser, LLC has disclosed COGT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Venrock Adviser, LLC's current position in COGT?
As of Q3 2026, Venrock Adviser, LLC holds 1.64M shares of COGT (COGENT BIOSCIENCES INC), valued at $52.58M, representing 2.55% of its reported portfolio and ranking #11.
Has Venrock Adviser, LLC been buying or selling COGT?
In the latest 13F filing (Q3 2026), Venrock Adviser, LLC held unchanged its position in COGT. The position peaked in Q1 2026 at 2.00M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.